Efficacy of Oral Chemotherapy with Capecitabine and Temozolomide (Captem) in Patients with Metastatic Neuroendocrine Tumors (NETS). A Single-Institution Experience

被引：0
|
作者：
Smiroldo, V [1 ]
Carnaghi, C. [1 ]
Lania, A. [1 ]
Bonifacio, C. [1 ]
Pepe, G. [1 ]
Zerbi, A. [1 ]
Rimassa, L. [1 ]
Lavezzi, E. [1 ]
Spaggiari, P. [1 ]
机构：
[1] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Rozzano, Italy
来源：
NEUROENDOCRINOLOGY | 2018年 / 106卷
关键词：
captem; metastatic neuroendocrine tumors;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H23
引用
收藏
页码：206 / 206
页数：1
相关论文
共 50 条
  • [1] Efficacy of oral chemotherapy with capecitabine and temozolomide (CapTem) in metastatic neuroendocrine tumors (NETs): A single-institution experience.
    Smiroldo, Valeria
    Carnaghi, Carlo
    Rimassa, Lorenza
    Personeni, Nicola
    Pressiani, Tiziana
    Bozzarelli, Silvia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [2] Efficacy of Oral Chemotherapy with Capecitabine and Temozolomide (CAPTEM) in Patients with Metastatic Neuroendocrine Tumors (NETS). A 5-Years Single-Institution Experience
    Smiroldo, V
    Bozzarelli, S.
    Lavezzi, E.
    Zerbi, A.
    Lania, A.
    Rimassa, L.
    Santoro, A.
    Carnaghi, C.
    [J]. NEUROENDOCRINOLOGY, 2019, 108 : 162 - 162
  • [3] Combination capecitabine/temozolomide (CAPTEM) in patients with neuroendocrine tumors (NETs): A single institution review.
    Ramirez, Robert A.
    Boudreaux, J. Philip
    Wang, Yi-Zarn
    Beyer, David T.
    Woltering, Eugene
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] A single center experience with oral chemotherapy with capecitabine and temozolomide in metastatic neuroendocrine tumors
    Rego, I.
    Pontes, F.
    Carvalho, J.
    Pratas, E.
    Chaves, A.
    Martins, R.
    Couto, J.
    Ribeiro, J.
    Rodrigues, F.
    Sousa, G.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [5] The Role of Capecitabine/Temozolomide (CAPTEM) in Metastatic Neuroendocrine Tumors: A Neuroendocrine Tumor Program Experience
    Ramirez, Robert A.
    Chauhan, Aman
    Beyer, David T.
    Boudreaux, J. Philip
    Wang, Yi-Zarn
    Woltering, Eugene A.
    [J]. PANCREAS, 2016, 45 (03) : 480 - 480
  • [6] SINGLE INSTITUTION EXPERIENCE WITH CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN HEAVILY PRE-TREATED PATIENTS WITH METASTATIC WELL AND POORLY DIFFERENTIATED NEUROENDOCRINE MALIGNANCIES
    Tran, Q.
    Bigby, K.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 67 - 67
  • [7] Capecitabine and temozolomide (CAPTEM) in patients with advanced neuroendocrine tumors: the experience of a Portuguese cancer center
    Chaves, A.
    Garcia, A.
    Ribeiro, J.
    Marques, M.
    Bonito, N.
    Jacinto, P.
    Gervasio, H.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 53 - 53
  • [8] Neoadjuvant Capecitabine/Temozolomide (CAPTEM) for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors
    Squires, M. H.
    Rossfeld, K. K.
    Konda, B.
    Shah, M.
    Dillhoff, M.
    Abdel-Misih, S.
    Pawlik, T.
    Cloyd, J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S138 - S139
  • [9] Capecitabine and temozolomide (CAPTEM) for intermediate to high grade metastatic neuroendocrine tumours (NET): A single centre experience
    Sahu, Arvind
    Jefford, Michael
    Lai-Kwon, Julia
    Hicks, Rod
    Thai, Alesha
    Michael, Michael
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 102 - 102
  • [10] Capecitabine and temozolomide (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors
    Dogan, Izzet
    Tastekin, Didem
    Karabulut, Senem
    Sakar, Burak
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2022, 23 (8-9) : 493 - 499
12345